DIVISLAB.NS
DIVISLAB.NS
INE361B01024
DIVI S LABORATORIES LTD
Loading chart...

Company Profile

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Related stocks

TORNTPHARM.NS
TORNTPHARM.NS • India
TORRENT PHARMACEUTICALS L
4,656.9 INR
18.3B USD 1Y +29.4%
SUNPHARMA.NS
SUNPHARMA.NS • India
SUN PHARMACEUTICAL IND L
1,760 INR
43.63B USD 1Y +7.9%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
LAURUSLABS.NS
LAURUSLABS.NS • India
LAURUS LABS LIMITED
2,036.6 INR
11.37B USD 1Y +135.4%
ZYDUSLIFE.NS
ZYDUSLIFE.NS • India
ZYDUS LIFESCIENCES LTD
1,117.5 INR
11.52B USD 1Y +12.8%
CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
26.9% p.a.
Max Drawdown (5Y)
-48.8%
Sharpe Ratio (5Y)
0.38
Beta Factor
0.23
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 84.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (26.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -57.6% in the extended horizon.
ende